← FDA Drug Approvals (Drugs@FDA)

RIVAROXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2026-02-20

Drug application

FDA Application #

ANDA218768

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVAROXABAN

Generic name

Rivaroxaban

Active ingredients

RIVAROXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

First approval

2026-02-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown